Dr. Jean-Pierre Issa Details the Positive Impacts of Reducing Caloric Intake | Temple Health
Investigators and Staff
The Myelodysplastic Syndrome as an Epigenetic Disease”
Dr. Jean-Pierre Issa, Temple U [IMAGE] | EurekAlert! Science News Releases
Pulling Back the Curtain: Allen Yang, MD, PhD
DNA methylation changes in aging cells and tissues | HSTalks
Dr. Jean-Pierre Issa, MD | Philadelphia, PA | Internal Medicine | Vitals
Our Faculty | Jean-Pierre Issa | Coriell Institute
PRWeek Pride in PR: Karine Jean-Pierre | PR Week
.jpg?mw=240 "The Team")
The Team
First clinical results of a randomized phase 2 study of SGI-110, a novel subcutaneous (SQ) hypomethylating agent (HMA), in adult
Jean-Pierre J. Issa's research works | Coriell Institute for Medical Research, Camden and other places
Epigenetic Therapy: What Is It, Where Are We, and What Do...
Dr. Jean-Pierre Issa, MD – Philadelphia, PA | Oncology
Prof. Jean-Pierre Issa | HSTalks
Microbiota Accelerates Age-Related CpG Island Methylation in Colonic Mucosa
Jean-Pierre J. Issa's research works | Coriell Institute for Medical Research, Camden and other places
Hussein A. Abbas | MD Anderson Cancer Center
Spotlight On: Jean-Pierre Issa, President and CEO, Coriell Institute for Medical Research - Capital Analytics
TAT 2011 presentation: Discovery and development of next generation epigenetic DNMT inhibitors: Development of SGI-110, a novel
Dr. Jean-Pierre Issa, MD - Oncology Specialist in Houston, TX | Healthgrades
Jean-Pierre Issa - President and CEO - Coriell Institute for Medical Research | LinkedIn
